AbbVie Inc. (ABBV) results explained: sales up 11%

Quantooo Lab · 2026-10-30

What happened?

AbbVie Inc. (ABBV) reported results on 30 Oct, covering the 9 months to 30 Sep.

The numbers in plain words

Sales were up 10.9% compared with the same period a year earlier. Out of every 100 of sales, about 34 was left after running costs (operating margin 33.8%), higher than a year earlier (23.6%). The company is funded more by borrowing than a year ago (103% of assets vs 102%).

Source: the company's 10-Q filed 2026-11-03.

How did the share price react?

Since the results, the share price has moved −1.65% (to the close of 3 Nov), while the S&P 500 moved −1.95%.

What changed in our score?

Our score went from 66 to 67 out of 100; the fundamentals part went from 54 to 64. Every step of the calculation: ABBV stock page.

How bumpy could the next month be?

Our volatility model expects the next month to be bumpier than usual for ABBV (25% a year vs a normal 24%).

What does it mean?

Results describe the past few months. They don't tell you where the price goes next, and our own tests found our scores don't reliably predict that either.

Educational, not investment advice.